Home > > North America And Global Vaccines Market- Size, Share, Growth Rate, and Forecast
The North America Vaccines market was valued at $24,241.8 Million in 2023, and is projected to reach $38,163.5 Million by 2030 growing at a CAGR of 6.75% from 2024 to 2030. Conjugate vaccines segment is expected to be the highest contributor to this market, with $8,858.0 Million in 2023, and is anticipated to reach $15,022.8 by 2030, registering a CAGR of 7.88%. Conjugate vaccines and Inactivated and subunit vaccines segments collectively expected to account for about 58.1% share of the North America Vaccines market in 2023, with the former constituting around 36.5% share. Conjugate vaccines and Inactivated and subunit vaccines segments are expected to witness significant growth rates at a CAGR of 7.88% and 7.02% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 58.1% in the overall North America Vaccines market in 2023, and is anticipated to reach 61.3% by 2030. Technology Conjugate vaccines Inactivated and subunit vaccines Live attenuated vaccines Recombinant vaccines Toxoid vaccines Type Monovalent vaccines Multivalent vaccines Route of Administration Intramuscular and subcutaneous administration Oral administration Other routes of administration BY REGION North America US Canada Europe Germany UK France Italy Spain RoE Asia Japan China India RoAPAC Middle East & Africa Latin America MEA